Shanghai Haohai Biological Technology Yönetim
Yönetim kriter kontrolleri 4/4
Shanghai Haohai Biological Technology CEO'su Jianying Wu, Jul2010 tarihinde atandı, in görev süresi 14.33 yıldır. şirketin hisselerinin 3.69% doğrudan sahiptir ve bu hisselerin değeri HK$ 515.66M dir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 9.9 yıl ve 11 yıldır.
Anahtar bilgiler
Jianying Wu
İcra Kurulu Başkanı
CN¥1.9m
Toplam tazminat
| CEO maaş yüzdesi | n/a |
| CEO görev süresi | 14.3yrs |
| CEO sahipliği | 3.7% |
| Yönetim ortalama görev süresi | 9.9yrs |
| Yönetim Kurulu ortalama görev süresi | 11yrs |
Son yönetim güncellemeleri
Recent updates
We Think Shanghai Haohai Biological Technology (HKG:6826) Can Manage Its Debt With Ease
Jul 25
Why We Think Shanghai Haohai Biological Technology Co., Ltd.'s (HKG:6826) CEO Compensation Is Not Excessive At All
May 22Shanghai Haohai Biological Technology (HKG:6826) Seems To Use Debt Rather Sparingly
Apr 17Are Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Investors Paying Above The Intrinsic Value?
Feb 12Is Shanghai Haohai Biological Technology (HKG:6826) Using Too Much Debt?
Nov 14Shanghai Haohai Biological Technology (HKG:6826) Has A Pretty Healthy Balance Sheet
Jul 28We Think Shanghai Haohai Biological Technology (HKG:6826) Can Stay On Top Of Its Debt
Mar 09These 4 Measures Indicate That Shanghai Haohai Biological Technology (HKG:6826) Is Using Debt Reasonably Well
Nov 25Shanghai Haohai Biological Technology (HKG:6826) Has A Pretty Healthy Balance Sheet
Jul 30Shanghai Haohai Biological Technology Co., Ltd.'s (HKG:6826) Intrinsic Value Is Potentially 96% Above Its Share Price
May 08Is Shanghai Haohai Biological Technology (HKG:6826) Using Too Much Debt?
Apr 19Analyst Forecasts Just Became More Bearish On Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826)
Mar 04Shanghai Haohai Biological Technology Co., Ltd. Just Missed Earnings - But Analysts Have Updated Their Models
Mar 03Is Shanghai Haohai Biological Technology (HKG:6826) A Risky Investment?
Jan 10Shanghai Haohai Biological Technology (HKG:6826) Seems To Use Debt Rather Sparingly
Oct 08Here's Why Shanghai Haohai Biological Technology (HKG:6826) Can Manage Its Debt Responsibly
Jul 07Analysts Have Just Cut Their Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Revenue Estimates By 14%
May 27These 4 Measures Indicate That Shanghai Haohai Biological Technology (HKG:6826) Is Using Debt Reasonably Well
Apr 04Investors Who Bought Shanghai Haohai Biological Technology (HKG:6826) Shares A Year Ago Are Now Up 58%
Mar 16CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | CN¥430m |
| Jun 30 2024 | n/a | n/a | CN¥446m |
| Mar 31 2024 | n/a | n/a | CN¥432m |
| Dec 31 2023 | CN¥2m | n/a | CN¥416m |
| Sep 30 2023 | n/a | n/a | CN¥346m |
| Jun 30 2023 | n/a | n/a | CN¥315m |
| Mar 31 2023 | n/a | n/a | CN¥226m |
| Dec 31 2022 | CN¥2m | CN¥855k | CN¥180m |
| Sep 30 2022 | n/a | n/a | CN¥203m |
| Jun 30 2022 | n/a | n/a | CN¥192m |
| Mar 31 2022 | n/a | n/a | CN¥272m |
| Dec 31 2021 | CN¥1m | CN¥845k | CN¥352m |
| Sep 30 2021 | n/a | n/a | CN¥428m |
| Jun 30 2021 | n/a | n/a | CN¥434m |
| Mar 31 2021 | n/a | n/a | CN¥370m |
| Dec 31 2020 | CN¥1m | CN¥768k | CN¥230m |
| Sep 30 2020 | n/a | n/a | CN¥232m |
| Jun 30 2020 | n/a | n/a | CN¥216m |
| Mar 31 2020 | n/a | n/a | CN¥279m |
| Dec 31 2019 | CN¥2m | CN¥742k | CN¥371m |
| Sep 30 2019 | n/a | n/a | CN¥353m |
| Jun 30 2019 | n/a | n/a | CN¥386m |
| Mar 31 2019 | n/a | n/a | CN¥375m |
| Dec 31 2018 | CN¥1m | CN¥712k | CN¥415m |
| Sep 30 2018 | n/a | n/a | CN¥411m |
| Jun 30 2018 | n/a | n/a | CN¥408m |
| Mar 31 2018 | n/a | n/a | CN¥390m |
| Dec 31 2017 | CN¥1m | CN¥583k | CN¥372m |
Tazminat ve Piyasa: Jianying 'nin toplam tazminatı ($USD 262.96K ), Hong Kong pazarındaki benzer büyüklükteki şirketler için ortalamanın altındadır ($USD 487.65K ).
Tazminat ve Kazançlar: Jianying 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.
CEO
Jianying Wu (60 yo)
14.3yrs
Görev süresi
CN¥1,904,800
Tazminat
Dr. Jianying Wu has been General Manager of Shanghai Haohai Biological Technology Co., Ltd. since July 23, 2010 and has been its Executive Director since December 2014. Mr. Wu served as a Director at Shang...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Executive Chairman | 14.3yrs | CN¥1.89m | 3.65% HK$ 510.4m | |
| GM & Executive Director | 14.3yrs | CN¥1.90m | 3.69% HK$ 515.7m | |
| CFO & Executive Director | 7.9yrs | CN¥1.45m | 0.036% HK$ 5.1m | |
| Executive Director | 9.9yrs | CN¥1.26m | 0.26% HK$ 36.1m | |
| Joint Company Secretary | 4.9yrs | CN¥868.70k | 0.0044% HK$ 618.2k | |
| Deputy General Manager | 10.2yrs | CN¥912.50k | 0.012% HK$ 1.7m | |
| Joint Company Secretary | 10yrs | Veri yok | Veri yok |
9.9yrs
Ortalama Görev Süresi
49yo
Ortalama Yaş
Deneyimli Yönetim: 6826 'un yönetim ekibi deneyimli ve deneyimlidir ( 9.9 yıldır).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Executive Chairman | 14.3yrs | CN¥1.89m | 3.65% HK$ 510.4m | |
| GM & Executive Director | 14.3yrs | CN¥1.90m | 3.69% HK$ 515.7m | |
| CFO & Executive Director | 7.8yrs | CN¥1.45m | 0.036% HK$ 5.1m | |
| Executive Director | 14.3yrs | CN¥1.26m | 0.26% HK$ 36.1m | |
| Independent Non-Executive Director | less than a year | Veri yok | Veri yok | |
| Non Executive Director | 14.3yrs | Veri yok | 47.38% HK$ 6.6b | |
| Non-Executive Director | 14.3yrs | CN¥150.00k | 1.22% HK$ 169.9m | |
| Chairman of the Supervisory Committee | 14.3yrs | Veri yok | 1.22% HK$ 169.9m | |
| Independent Non-Executive Director | 4.4yrs | CN¥150.00k | Veri yok | |
| Independent Non-Executive Director | 4.4yrs | CN¥150.00k | Veri yok | |
| Independent Non-Executive Director | 4.4yrs | CN¥150.00k | Veri yok | |
| Independent Non-Executive Director | 4.4yrs | CN¥150.00k | Veri yok |
11.0yrs
Ortalama Görev Süresi
52.5yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: 6826 'in yönetim kurulu deneyimli ve tecrübelidir (ortalama görev süresi 11 yıldır).